SCHEMBL23733159

SCHEMBL23733159

CS(=O)(=O)N(C(=O)C(=O)O)C(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.47
NR3C2 P08235 2/20 0.43
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
PTGS2 P35354 1/20 0.38
AKR1C2 P52895 1/20 0.38
AKR1C1 Q04828 1/20 0.38
POLB P06746 1/20 0.38
CES2 O00748 2/20 0.37
CES1 P23141 2/20 0.37
DAO P14920 1/20 0.37
TSHR P16473 1/20 0.37
NAPRT Q6XQN6 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
CASP3 P42574 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23699763 0.92 HSD11B1 (0.50) HSD11B1NR3C2ALDH1A1HPGDL3MBTL1
SCHEMBL23733156 0.83 TSHR (0.43) HSD11B1NR3C2ALDH1A1HPGDL3MBTL1
SCHEMBL23733149 0.80 ELANE (0.44) HSD11B1NR3C2ALDH1A1HPGDL3MBTL1
SCHEMBL23733161 0.80 HSD11B1 (0.59) HSD11B1ALDH1A1L3MBTL1TSHRKMT2A
SCHEMBL21897070 0.79 NR3C2 (0.40) HSD11B1NR3C2ALDH1A1HPGDL3MBTL1
SCHEMBL1021022 0.79 HSD11B1 (0.45) HSD11B1NR3C2ALDH1A1HPGDL3MBTL1
Hydrochloric Acid SCHEMBL8178064 0.77 HSD11B1 (0.44) HSD11B1NR3C2ALDH1A1HPGDL3MBTL1
SCHEMBL27499593 0.76 HSD11B1 (0.42) HSD11B1NR3C2ALDH1A1HPGDL3MBTL1
SCHEMBL23733160 0.76 HSD11B1 (0.45) HSD11B1NR3C2ALDH1A1HPGDL3MBTL1
SCHEMBL11832256 0.76 HSD11B1 (0.52) HSD11B1NR3C2ALDH1A1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238155-A1 CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL DISORDERS GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238155-A1 CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL DISORDERS PYGL, HMOX2, MB HSD11B1 602/4885NR3C2 1104/4885ALDH1A1 976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.